Ann Marie K Weideman, Kevin J Anstrom, Gary G Koch, Xianming Tan
{"title":"Preservation of Type I Error for Partially-Unblinded Sample Size Re-Estimation.","authors":"Ann Marie K Weideman, Kevin J Anstrom, Gary G Koch, Xianming Tan","doi":"10.1002/sim.70030","DOIUrl":null,"url":null,"abstract":"<p><p>Sample size re-estimation (SSR) at an interim analysis allows for adjustments based on accrued data. Existing strategies rely on either blinded or unblinded methods to inform such adjustments and, ideally, perform these adjustments in a way that preserves Type I error at the nominal level. Here, we propose an approach that uses partially-unblinded methods for SSR for both binary and continuous endpoints. Although this approach has operational unblinding, its partial use of the unblinded information for SSR does not include the interim effect size, hence the term 'partially-unblinded.' Through proof-of-concept and simulation studies, we demonstrate that these adjustments can be made without compromising the Type I error rate. We also investigate different mathematical expressions for SSR under different variance scenarios: homogeneity, heterogeneity, and a combination of both. Of particular interest is the third form of dual variance, for which we provide additional clarifications for binary outcomes and derive an analogous form for continuous outcomes. We show that the corresponding mathematical expressions for the dual variance method are a compromise between those for variance homogeneity and heterogeneity, resulting in sample size estimates that are bounded between those produced by the other expressions, and extend their applicability to adaptive trial design.</p>","PeriodicalId":21879,"journal":{"name":"Statistics in Medicine","volume":"44 6","pages":"e70030"},"PeriodicalIF":1.8000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Statistics in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/sim.70030","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MATHEMATICAL & COMPUTATIONAL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Sample size re-estimation (SSR) at an interim analysis allows for adjustments based on accrued data. Existing strategies rely on either blinded or unblinded methods to inform such adjustments and, ideally, perform these adjustments in a way that preserves Type I error at the nominal level. Here, we propose an approach that uses partially-unblinded methods for SSR for both binary and continuous endpoints. Although this approach has operational unblinding, its partial use of the unblinded information for SSR does not include the interim effect size, hence the term 'partially-unblinded.' Through proof-of-concept and simulation studies, we demonstrate that these adjustments can be made without compromising the Type I error rate. We also investigate different mathematical expressions for SSR under different variance scenarios: homogeneity, heterogeneity, and a combination of both. Of particular interest is the third form of dual variance, for which we provide additional clarifications for binary outcomes and derive an analogous form for continuous outcomes. We show that the corresponding mathematical expressions for the dual variance method are a compromise between those for variance homogeneity and heterogeneity, resulting in sample size estimates that are bounded between those produced by the other expressions, and extend their applicability to adaptive trial design.
期刊介绍:
The journal aims to influence practice in medicine and its associated sciences through the publication of papers on statistical and other quantitative methods. Papers will explain new methods and demonstrate their application, preferably through a substantive, real, motivating example or a comprehensive evaluation based on an illustrative example. Alternatively, papers will report on case-studies where creative use or technical generalizations of established methodology is directed towards a substantive application. Reviews of, and tutorials on, general topics relevant to the application of statistics to medicine will also be published. The main criteria for publication are appropriateness of the statistical methods to a particular medical problem and clarity of exposition. Papers with primarily mathematical content will be excluded. The journal aims to enhance communication between statisticians, clinicians and medical researchers.